Protooncogenes in the regulation of normal hematopoiesis. An antisense approach.
Calabretta
B
B
Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Skorski
T
T
Szczylik
C
C
Caracciolo
D
D
Valtieri
M
M
Venturelli
D
D
D015703:Antigens, CD / Q000096:biosynthesis; D018952:Antigens, CD34; D005786:Gene Expression Regulation / Q000187:drug effects*; D016313:Genes, abl / Q000235:genetics; D011905:Genes, ras / Q000235:genetics; D006410:Hematopoiesis / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D011519:Proto-Oncogenes / Q000235:genetics*; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D018952:Antigens, CD34; D007377:Interleukin-3; D009838:Oligodeoxyribonucleotides; D016376:Oligonucleotides, Antisense